Although traditionally ketones have been viewed with distrust by the medical community, today they are increasingly understood as both an important oxidative fuel and pleiotropic signaling metabolites. Recent data has illustrated the potential for broad applications of ketosis in health and disease; for example for athletic performance and recovery, cognitive performance, neurodegeneration, metabolic health and cardiovascular health. There is an urgent need for work that refines our mechanistic understanding of ketosis in each of these use cases as well as interrogating further proposed use cases.
The proposed Research Topic will contain emerging research results related to various aspects of ketone biology on health, resilience and performance. The envisioned special collection will discuss the most recent research regarding methods of achieving ketosis (e.g., ketogenic diet, exogenous ketones) and the broad impacts of ketosis in health and disease.
The envisioned collection will contain emerging research results related to various aspects of ketone biology on health, resilience and performance. The scope of this special collection will include the ketogenic diet, exogenous ketones, and the broad impacts of ketosis in health and disease. Both animal and human studies are within the scope of this special collection. Primary research as well as review papers are welcome.
Topic Editor Dr. Ken Ford serves on Abbott Diabetes Care: Glucose Advisory Board and the Virta Scientific Advisory Board.
Topic Editor Dr. Brianna Stubbs has stock options in BHB Therapeutics Ltd., Selah Therapeutics Ltd., Juvenescence Ltd. and Readout Health Ltd.. She is also an inventor of patents related to the method of use for ketone bodies.
Topic Editor Dr. Jeff Volek has Co-founder equity in Virta Health and serves on Scientific Advisory Boards: Simply Good Foods, UCAN, Abbott's Sensors in Ketogenic Diet and royalties from low-carbohydrate books.
Topic Editor Dr. Brendan Egan has no competing interests to declare.
Although traditionally ketones have been viewed with distrust by the medical community, today they are increasingly understood as both an important oxidative fuel and pleiotropic signaling metabolites. Recent data has illustrated the potential for broad applications of ketosis in health and disease; for example for athletic performance and recovery, cognitive performance, neurodegeneration, metabolic health and cardiovascular health. There is an urgent need for work that refines our mechanistic understanding of ketosis in each of these use cases as well as interrogating further proposed use cases.
The proposed Research Topic will contain emerging research results related to various aspects of ketone biology on health, resilience and performance. The envisioned special collection will discuss the most recent research regarding methods of achieving ketosis (e.g., ketogenic diet, exogenous ketones) and the broad impacts of ketosis in health and disease.
The envisioned collection will contain emerging research results related to various aspects of ketone biology on health, resilience and performance. The scope of this special collection will include the ketogenic diet, exogenous ketones, and the broad impacts of ketosis in health and disease. Both animal and human studies are within the scope of this special collection. Primary research as well as review papers are welcome.
Topic Editor Dr. Ken Ford serves on Abbott Diabetes Care: Glucose Advisory Board and the Virta Scientific Advisory Board.
Topic Editor Dr. Brianna Stubbs has stock options in BHB Therapeutics Ltd., Selah Therapeutics Ltd., Juvenescence Ltd. and Readout Health Ltd.. She is also an inventor of patents related to the method of use for ketone bodies.
Topic Editor Dr. Jeff Volek has Co-founder equity in Virta Health and serves on Scientific Advisory Boards: Simply Good Foods, UCAN, Abbott's Sensors in Ketogenic Diet and royalties from low-carbohydrate books.
Topic Editor Dr. Brendan Egan has no competing interests to declare.
